trials ( presently in progress ) are designed to evaluate the hypothesis that converting-enzyme inhibitors exert beneficial effects on the survival of patients with congestive heart failure comparable to those reported with hydralazine and isosorbide dinitrate .
C0018802
congestive heart failure
C0020223
hydralazine